DeepMed Research

CENTRE ANTOINE LACASSAGNE

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 1961-01-01

Employees: -

Market Cap: -

Website: http://www.centreantoinelacassagne.org/fr

Clinical Trials

Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter

Not Applicable

Terminated

Conditions: Malignant Mast Cell Tumors
Solid Organ Sites

First Posted Date: 2012-06-11

Last Posted Date: 2015-11-16

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 990

Registration Number: NCT01616537

Locations: 🇫🇷
Centre Paul Papin - Ico, Angers, France
🇫🇷
Centre Francois Baclesse, Caen, France
🇫🇷
Chu La Timone, Marseille, France

and more 7 locations

Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Drug: capecitabine
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2009-08-06

Last Posted Date: 2015-02-10

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 303

Registration Number: NCT00953537

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Stereotactic Radiosurgery in Treating Patients Undergoing Chemotherapy and Radiation Therapy For Stage III Non-Small Cell Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Device: CK

First Posted Date: 2009-07-24

Last Posted Date: 2019-09-16

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 35

Registration Number: NCT00945451

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Sunitinib Malate in Treating Patients With Kidney Cancer

Not Applicable

Completed

Conditions: Kidney Cancer

Interventions: Drug: sunitinib malate
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2009-07-22

Last Posted Date: 2016-11-10

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 60

Registration Number: NCT00943839

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Trastuzumab in Treating Women With Metastatic Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Biological: trastuzumab
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2009-05-11

Last Posted Date: 2015-02-10

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 49

Registration Number: NCT00896376

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: capecitabine
Drug: erlotinib hydrochloride
Drug: gemcitabine hydrochloride

First Posted Date: 2009-04-21

Last Posted Date: 2015-02-10

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 30

Registration Number: NCT00885066

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Biological: cetuximab
Drug: cisplatin
Radiation: radiation therapy

First Posted Date: 2009-04-03

Last Posted Date: 2014-11-21

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 53

Registration Number: NCT00875849

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Procedure: magnetic resonance imaging
Procedure: radiomammography
Procedure: ultrasound imaging

First Posted Date: 2009-04-02

Last Posted Date: 2014-11-21

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 40

Registration Number: NCT00874458

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: cyclophosphamide
Drug: docetaxel
Drug: epirubicin hydrochloride
Drug: fluorouracil
Procedure: neoadjuvant therapy
Procedure: therapeutic conventional surgery
Radiation: hypofractionated radiation therapy
Radiation: image-guided radiation therapy
Radiation: radiation therapy
Radiation: stereotactic radiosurgery

First Posted Date: 2009-03-31

Last Posted Date: 2015-02-10

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 26

Registration Number: NCT00872625

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract

Phase 3

Completed

Conditions: Head and Neck Cancer
Infection
Malnutrition

Interventions: Other: placebo
Dietary Supplement: therapeutic nutritional supplementation

First Posted Date: 2008-10-03

Last Posted Date: 2015-02-10

Lead Sponsor: Centre Antoine Lacassagne

Target Recruit Count: 311

Registration Number: NCT00765440

Locations: 🇫🇷
Centre Antoine Lacassagne, Nice, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy